束花石斛化学成分研究

目的 对束花石斛三氯甲烷部位进行化学成分研究.方法 采用硅胶柱层析、ODS柱色谱、Sephadex LH-20柱色谱及重结晶等方法对束花石斛三氯甲烷部位进行分离纯化,并通过理化性质与核磁、质谱等光谱分析方法鉴定化合物的结构.结果 分离鉴定出10个单体化合物,分别为纽替皂苷元-26-O-β-D-吡喃葡萄糖苷(1)、2,7-二羟基-4-甲氧基-9-芴酮(2)、dengibsinin(3)、chrysotoxone (4)、丁香醛(5)、对羟基苯甲醛(6)、香草酸(7)、三十一烷醇(8)、十六烷酸(9)、大黄酚(10).结论 化合物1为首次从石斛属植物中分离得到,也是首次在束花石斛中发现变形螺甾烷醇类甾体皂苷.     

木香降血糖有效部位及有效成分研究

目的 筛选木香中降血糖活性部位及主要成分。方法 制备木香乙醇提取物,乙醇提取物醋酸乙酯部位、正丁醇部位和水提取部位;用HepG2细胞消耗葡萄糖模型和四氧嘧啶致糖尿病小鼠模型测定各提取物的降血糖活性;降血糖活性强的醋酸乙酯部位用柱色谱法继续分离、精制,得2个化合物,经NMR等鉴定化合物结构;并对2个化合物进行降血糖活性研究。结果 木香醋酸乙酯部位有较强的降血糖作用,从木香醋酸乙酯部位中分离得到木香烃内酯和去氢木香内酯,且两者均可降低四氧嘧啶所致糖尿病小鼠的血糖,并显示很好的抗氧化作用。结论 木香烃内酯和去氢木香内酯可能是木香的降血糖活性成分,抑制氧化应激从而减轻胰岛素抵抗可能是其降血糖机制。     

紫花地丁化学成分研究

目的 研究紫花地丁Viola yedoensis 药效活性部位醋酸乙酯提取物的化学成分。方法 利用现代化学成分分离纯化技术进行分离纯化,根据化合物的理化性质和光谱数据进行结构鉴定。结果 从该部位分离鉴定了15个化合物,分别鉴定为木犀草素(1)、芹菜素(2)、槲皮素(3)、5,7-二羟基3,6-二甲氧基黄酮(4)、柚皮素(5)、芦丁(6)、7-羟基-8-甲氧基香豆素(7)、秦皮乙素(8)、咖啡酸(9)、2-羟基-1-(4-羟基-3-甲氧基)苯基-1-丙酮(10)、3,4-二羟基苯甲酸(11)、3-羟基-4-甲氧基苯甲酸甲酯(12)、奎宁酸(13)、4-muurolene3,10-diol(14)、β-谷甾醇(15)。结论 除化合物8和15外,其余13个化合物均为首次从该植物中分得。化合物4、5、7、9～14为首次从该属植物中分得。     

金钗石斛中的酚性成分

目的对金钗石斛茎的化学成分进行研究。方法运用多种色谱学技术对金钗石斛的化学成分进行分离,并根据光谱数据鉴定化合物的结构。结果从该植物中分离得到12个酚性化合物,其结构分别为二氢松柏醇二氢对羟基桂皮酸酯(Ⅰ),香草醛(Ⅱ),罗布麻宁(Ⅲ),对羟基苯甲醛(Ⅳ),丁香醛(Ⅴ),丁香酸(Ⅵ),丁香乙酮(Ⅶ),α-羟基丁香丙酮(Ⅷ),松柏醛(Ⅸ),二氢松柏醇(Ⅹ),2-羟基苯丙醇(Ⅺ)和3-羟基-4-甲氧基苯乙醇(Ⅻ)。结论上述化合物均为首次报道从金钗石斛中分离得到,化合物Ⅰ,Ⅲ~Ⅻ为首次报道从石斛属植物中分离得到。     

密脉鹅掌柴的化学成分及其抗肿瘤活性

目的 阐明民间用于癌症治疗的密脉鹅掌柴Schefflera venulosa的化学成分及其抗肿瘤活性。方法 用小鼠乳腺癌tsFT210细胞的流式细胞术筛选模型，确定抗肿瘤活性部位；利用Sephadex LH-20、硅胶等柱色谱，分离活性部位的化学成分；根据理化性质和波谱数据鉴定化合物的化学结构，用流式细胞术和SRB法初步评价化合物对tsFT210和K562细胞的抗肿瘤活性。结果 从密脉鹅掌柴活性部位分离鉴定了9个化合物：2-羟基-3苯胺羰基-1-偶氮苯基-萘(Ⅰ)、大黄酚(Ⅱ)、2，6-二甲氧基对苯醌(Ⅲ)、正十六烷酸(Ⅳ)、正十八烷酸(Ⅴ)、正二十六烷酸(Ⅵ)、4，22-二烯-3-酮豆甾烷(Ⅶ)、5，22-二烯-7-酮-3β-羟基豆甾烷(Ⅶ)和β-谷甾醇(Ⅸ)；活性测试结果表明化合物Ⅱ、Ⅲ对K562细胞有增殖抑制活性，其IC50值分别为52．50和25．50μg／mL，化合物Ⅳ对在30μg／mL的低浓度对tsFT210细胞具有细胞周期G2／M期抑制活性，而在100μg／mL的高浓度时却呈现显著的细胞周期G2／M期抑制和细胞凋亡诱导活性。结论 化合物Ⅰ为新天然产物，中文俗名为808猩红(808Scarlet)，除β-谷甾醇外，其余均系首次从密脉鹅掌柴中分离得到。化合物Ⅲ的抗肿瘤活性为首次发现，化合物Ⅱ～Ⅳ为该植物抗肿瘤活性成分为首次报道。     

两色紫金牛化学成分研究

目的 研究两色紫金牛的活性化学成分.方法 应用柱色谱分离化学成分,波谱方法鉴定化合物结构.结果 从两色紫金牛脂溶性部位得到5个化合物,分别鉴定为岩白菜素(1),11-O-(3‘,5‘-二羟基-4‘-甲氧基没食子酰基)-岩白菜素(2),11-O-(3‘,4‘,5‘-三羟基没食子酰基)-岩白菜素(3),β-谷甾醇(4)和豆甾醇(5).结论 化合物1～5均为首次从该种植物中分离得到,其中化合物2为首次从该属植物中分离得到.     

铁皮石斛化学成分的研究

目的 研究铁皮石斛 Dendrobium candidum 水提物醋酸乙酯萃取物的化学成分。方法 采用硅胶柱色谱、ODS柱色谱、高效液相色谱等多种色谱学方法进行分离和纯化,根据波谱学特征鉴定化合物的结构。结果 共分离得到11个化合物,分别鉴定为(E)-对羟基桂皮酸(Ⅰ)、对羟基苯丙酸(Ⅱ)、松柏醇(Ⅲ)、香草醇(Ⅳ)、穆坪马兜铃酰胺(Ⅴ)、顺式阿 魏酸酰对羟基苯乙胺(Ⅵ)、反式桂皮酸酰对羟基苯乙胺(Ⅶ)、4′,5-二羟基3,3′-二甲氧基联苄(Ⅷ)、丁香脂素(Ⅸ)、4-烯丙基2,6-二甲氧基苯基葡萄糖苷(Ⅹ)和柚皮素(Ⅺ)。结论 化合物Ⅰ、Ⅳ～Ⅶ和Ⅹ为首次从石斛属植物中分离得到,所有化合物均为首次从铁皮石斛中分离得到。     

小蓟止血活性部位的化学成分研究

目的:研究小蓟(Cirsium setosum)止血活性部位的化学成分。方法:运用硅胶柱色谱及HPLC制备色谱对小蓟止血活性部位进行分离纯化,根据化合物的理化性质和波谱数据鉴定结构。结果:从小蓟止血活性部位中共分离鉴定了9个化合物,分别为1-(3′,4′-二羟基肉桂酰)-环戊-2,3-二酚(1)、5-O-咖啡酰基奎宁酸(2)、绿原酸(3)、咖啡酸(4)、原儿茶酸(5)、原儿茶醛(6)、刺槐素(7)、蒙花苷(8)和芦丁(9)。结论:化合物1为首次从蓟属植物中分离得到,化合物2为首次从本植物中分离得到。     

地椒抗氧化活性部位化学成分的研究?

目的研究地椒抗氧化活性成分,阐明地椒抗氧化活性化学成分组成。方法采用1,1-diphenyl-2-picrylhydrazyl(DPPH)和2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)(ABTS)自由基清除试验筛选评价地椒5个极性部位的抗氧化活性;采用硅胶、Sephadex LH-20和MCI GEL CHP-20P等柱色谱方法进行分离纯化,并根据质谱、核磁数据和参考文献数据等鉴定化合物的结构。结果地椒乙酸乙酯层和正丁醇层显示很好的抗氧化活性。从该两萃取层中,分离鉴定18个化合物分别为野黄芩苷(1),野黄芩素(2),5,6,7-三羟基-4'-甲氧基黄酮(3),4'5-二羟基-6,7,8,-三甲氧基黄铜(xanthomicrol)(4),芹菜素(5),4'-甲氧基木犀草素(6),木犀草苷(7),木犀草素(8),芦丁(9),丹参素(10),香草酸(11),原儿茶酸(12),绿原酸(13),咖啡酸(14),阿魏酸(15),2,6-二羟基-4-异丙基-β-D-葡萄糖苷(16),齐墩果酸(17)和胡萝卜苷(18)。结论化合物1~3和16首次从百里香属植物中分离得到,化合物4~8,10~12,14~15和17~18首次从地椒植物中分离得到。     

鼓槌石斛化学成分的研究

目的 研究鼓槌石斛的化学成分，为阐明其活性成分，开发其资源提供科学依据。方法 采用硅胶柱层析法进行分离，根据光谱数据鉴定结构。结果 从中分得4个化合物，分别为：2，4，7－三羟基－9，10－二氢菲（Ⅰ），2，7－二羟基－3，4，6－三甲氧基菲(Ⅱ），5，4′－二羟基－3，3′－二甲氧基联苄（Ⅲ），3，4－二羟基苯甲酸（Ⅳ）。结论 化合物Ⅰ-Ⅳ均为首次从石斛属植物中分得。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Acupuncture Treatment of Vomiting

CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.     

Qiu Baoguo''''s Experience in Treating Consumptive Syndromes after Radio-Chemotherapies

Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.     

Insomnia Due to Deficiency of Both the Heart and Spleen Treated by Acupuncture-Moxibustion and Chinese Tuina

OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.